ALFA FinderBSE filing, NSE: SUDARSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Sudarshan Chemical Industries Ltd: key numbers
- Share price
- ₹1,066.60
- Market cap
- ₹8,494 Cr
- Revenue (annual)
- ₹9,787 Cr
- Net profit (annual)
- ₹22.30 Cr
- P/E (TTM)
- 96.2×Sector 28.2×
- Promoter holding
- 9.32%+1.13% QoQ
- FII holding
- 8.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Chemical Industries Ltd
All →Sudarshan Chemical Industries Investor Presentation: Key Takeaways
Q2 FY27 One Sudarshan revenue ₹2,743 Cr (+14.9% YoY), business EBITDA ₹239 Cr (8.7% margin, +4.7pp). Integration progressing; VP4 sale completed 2 Nov 2026.
Sudarshan Chemical Industries Q2 FY27 Results: Net Profit ₹30.5 Cr, Up 58.0% YoY
Sudarshan Chemical Industries Ltd reported revenue from operations of ₹2,743 Cr (+14.9% YoY) and net profit of ₹30.5 Cr (+58.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹30.5 Cr · +58.0% YoY
Sudarshan Chemical Industries Board Meeting Date
Sudarshan Chemical schedules a 6 November 2026 board meeting to consider unaudited quarterly and half-year results. Trading window stays closed until 8 November 2026.
Sudarshan Chemical Industries Merger & Restructuring Worth ₹795.9 Cr
Sudarshan Chemical completed sale of VP4 Frankfurt GmbH to Celanese for about Rs 795.9 crore. VP4 Frankfurt is no longer a step-down subsidiary.
- Value
- ₹795.9 Cr
Sudarshan Chemical Industries Employee Stock Options
Sudarshan Chemical allotted 19,350 equity shares to employees exercising options under its 2018 ESOP plan. The allotment is at an exercise price of Rs 349.35 per share.
Sudarshan Chemical Industries Credit Rating
India Ratings has revised the outlook on Sudarshan Chemical Industries' debt facilities to Positive from Stable, while affirming the existing credit ratings.
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.